The Illusion of Progress: Are New Cancer Drugs Failing Patients?
The landscape of modern oncology is characterized by a paradox: as the pharmaceutical industry accelerates the production of innovative, high-priced anticancer agents, the long-term prognosis for many patients remains stubbornly…